2022-03-072022-03-072005-06Kılıç, S. Ş. (2005). "Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency". Journal of Tropical Pediatrics, 51(3), 194-195.0142-6338https://doi.org/10.1093/tropej/fmi027https://academic.oup.com/tropej/article/51/3/194/1646327http://hdl.handle.net/11452/24866eninfo:eu-repo/semantics/openAccessPediatricsTropical medicineRheumatoid-arthritisAntibodies, monoclonalAntirheumatic agentsArthritis, juvenile rheumatoidChildCommon variable immunodeficiencyDose-response relationship, drugDrug administration scheduleFollow-up studiesHumansMaleRisk assessmentSeverity of illness indexTreatment outcomeArticle0002295452000142-s2.0-2394452694019419551315855303PediatricsTropical medicineCommon Variable Immunodeficiency; Immunoglobulin Deficiency; ImmunosuppressionAntirheumatic agentCorticosteroid derivativeImmunoglobulinInfliximabMethotrexateNonsteroid antiinflammatory agentTumor necrosis factorTumor necrosis factor alphaAntirheumatic agentInfliximabMonoclonal antibodyCase reportClinical featureClinical trialCommon variable immunodeficiencyDemyelinationDisease exacerbationDrug hypersensitivityDrug infusionDrug infusion reactionElbow diseaseFeverFibrosing alveolitisFollow upHumanImmunological parametersInfectionJuvenile rheumatoid arthritisKnee arthritisKnee painLaboratory testLetterMaleMalignant neoplastic diseasePhysical examinationSchool childSplenomegalyTreatment outcomeTuberculosisArticleChildCommon variable immunodeficiencyDose responseDrug administrationHospitalizationImmunologyRisk assessment